Progesterone at high doses reduces the growth of U87 and A172 glioblastoma cells: Proteomic changes regarding metabolism and immunity

While pregnancy may accelerate glioblastoma multiforme (GBM) growth, parity and progesterone (P4) containing treatments (ie, hormone replacement therapy) reduce the risk of GBM development. In parallel, low and high doses of P4 exert stimulating and inhibitory actions on GBM growth, respectively. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Altinoz, Meric A., Ucal, Yasemin, Yilmaz, Muazzez C., Kiris, İrem, Ozisik, Ozan, Sezerman, Ugur, Ozpinar, Aysel, Elmaci, İlhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433824/
https://www.ncbi.nlm.nih.gov/pubmed/32590878
http://dx.doi.org/10.1002/cam4.3223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433824/
https://www.ncbi.nlm.nih.gov/pubmed/32590878
http://dx.doi.org/10.1002/cam4.3223

Ejemplares similares